Atlas Trials

Hyperparathyroidism, Secondary

32 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hyperparathyroidism, Secondary

RecordFirmDate
Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease (NCT03063190)University of Sao Paulo General Hospital2022-03-31
Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment (NCT05347082)Hospital Regional 1o de Octubre2021-04-29
Study on the Use of Cinacalcet in Phosphocalcic Context. (NCT04126954)Hospices Civils de Lyon2020-01-01
Impact of Parathyroidectomy on Vascular Calcification and Clinical Outcome in Hemodialysis Patients (NCT03724188)Mansoura General Hospital2017-11-30
Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy (NCT05382988)Guangdong Provincial People's Hospital2016-11-01
Optimal Anemia Treatment in End Stage Renal Disease (ERSD) (NCT02273570)Azienda Ospedaliera Sant'Anna2015-03-01
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid (NCT02274623)OPKO Health, Inc.2014-12-01
Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation (NCT02523209)Centre Hospitalier Universitaire de Saint Etienne2014-09-01
Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis (NCT02102204)Amgen2014-03-25
The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid (NCT02056730)Chulalongkorn University2013-11-01
A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis (NCT01922843)Deltanoid Pharmaceuticals2013-09-01
Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide (NCT01932970)Amgen2013-08-12
Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis (NCT01785875)Amgen2013-07-31
Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 (NCT02282813)OPKO Health, Inc.2013-04-01
Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis (NCT01785849)Amgen2013-03-12
Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency (NCT01704079)OPKO IP Holdings II, Inc.2012-11-01
Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency (NCT01651000)OPKO IP Holdings II, Inc.2012-09-01
Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under Dialysis (NCT02464072)University of Sao Paulo General Hospital2012-07-01
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism (NCT01439867)Amgen2012-06-22
Pediatric Chronic Kidney Disease Safety and Efficacy (NCT01277510)Amgen2011-06-28
Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease (NCT01290029)Amgen2011-01-25
Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis (NCT01181531)Amgen2010-10-01
Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism (NCT01134562)KAI Pharmaceuticals2010-09-07
Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers (NCT01134549)KAI Pharmaceuticals2010-06-09
Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients (NCT00646282)Emory University2008-04-01
Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease (NCT00995163)Kyowa Kirin Co., Ltd.2008-01-01
How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis (NCT00528788)Duke University2007-09-01
Oral Paricalcitol in Kidney Transplant Recipients (NCT00587158)Mayo Clinic2007-01-01
Evaluation of Colecalciferol Substitution in Dialysis Patients (NCT00397475)University Hospital, Saarland2006-11-01
CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients (NCT00211939)Nabi Biopharmaceuticals2005-01-01

Track Hyperparathyroidism, Secondary automatically

Every clearance here is in the API, with alerts when new ones post.